The present invention relates to novel oxyindole derivatives of formula (I) or a pharmaceutically acceptable salt thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the motilin receptor (GPR38).
本发明涉及公式(I)的新型氧化
吲哚衍
生物或其药学上可接受的盐,其制备方法,含有它们的制药组合物以及它们在治疗通过胃动素受体(GPR38)介导的各种疾病中的使用。